NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Maven Bio

Maven Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://mavenbio.com/

Last Round

Seed

Apr 17, 2025

Total Funding Raised

$3.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Maven Bio is a healthcare technology company that provides an AI-powered platform for biopharma market intelligence to help life science consultants, investors, and corporate teams analyze therapeutic opportunities.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, Vertical SaaS, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

biopharma market intelligenceai for biopharmacompetitive intelligencebiopharma ai platformbiotech copilotindication landscapestherapeutic area analysisai research assistantlife science consulting toolsbiotech investment toolsautomated reportingclinical trial intelligencevertical saashealthcare analyticsusage-based pricing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Maven Bio Comps

Public and private peers based on sector, stage, and business model.

Maven Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Maven Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 17, 2025
AcceleratorSep 6, 2023

Maven Bio Investors

Notable investors and investment history

Maven Bio investors
InvestorRounds
NVO CapitalSeed
Pags GroupSeed
Y CombinatorAccelerator, Seed
Splash CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 250% MoM, reaching 7.3K.

  • Oct 8, 2025

    Added Insmed Incorporated, a biopharmaceutical company, as a customer.

Maven Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Maven Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Maven Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range11
Year Founded2023
Last FundingApr 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.